ATE191472T1 - Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE191472T1
ATE191472T1 AT96921482T AT96921482T ATE191472T1 AT E191472 T1 ATE191472 T1 AT E191472T1 AT 96921482 T AT96921482 T AT 96921482T AT 96921482 T AT96921482 T AT 96921482T AT E191472 T1 ATE191472 T1 AT E191472T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
containing same
metalloprotease inhibitors
inhibitors
Prior art date
Application number
AT96921482T
Other languages
English (en)
Inventor
David A Campbell
Dinesh V Patel
Xiao Y Xiao
Original Assignee
Affymax Tech Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymax Tech Nv filed Critical Affymax Tech Nv
Application granted granted Critical
Publication of ATE191472T1 publication Critical patent/ATE191472T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96921482T 1995-06-07 1996-06-06 Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen ATE191472T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48425595A 1995-06-07 1995-06-07
US08/549,345 US5831004A (en) 1994-10-27 1995-10-27 Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
PCT/US1996/009932 WO1996040738A1 (en) 1995-06-07 1996-06-06 Novel inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use

Publications (1)

Publication Number Publication Date
ATE191472T1 true ATE191472T1 (de) 2000-04-15

Family

ID=27047928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921482T ATE191472T1 (de) 1995-06-07 1996-06-06 Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen

Country Status (7)

Country Link
US (3) US5831004A (de)
EP (1) EP0832100B1 (de)
AT (1) ATE191472T1 (de)
AU (1) AU700239B2 (de)
CA (1) CA2222923A1 (de)
DE (1) DE69607615T2 (de)
WO (1) WO1996040738A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831004A (en) * 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
US6811995B1 (en) * 1996-04-26 2004-11-02 Children's Medical Center Corporation Non-invasive enzyme screen for cancer
TW424083B (en) * 1996-07-10 2001-03-01 American Cyanamid Co Mercaptoketones and mercaptoalcohols and a process for their prepartation
US5852213A (en) * 1996-07-10 1998-12-22 American Cyanamid Company Mercaptoketones and mercaptoalcohols and a process for their preparation
US6541276B2 (en) 1996-10-28 2003-04-01 Versicor, Inc. Methods for solid-phase synthesis of hydroxylamine compounds and derivatives and combinatorial libraries thereof
US6281245B1 (en) * 1996-10-28 2001-08-28 Versicor, Inc. Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof
US6034136A (en) 1997-03-20 2000-03-07 Novartis Ag Certain cyclic thio substituted acylaminoacid amide derivatives
US6204279B1 (en) * 1998-06-03 2001-03-20 Microcide Pharmaceuticals, Inc. Peptidomimetic efflux pump inhibitors
AU2337599A (en) * 1998-01-23 1999-08-09 Microcide Pharmaceuticals, Inc. Efflux pump inhibitors
HRP20000904A2 (en) * 1998-07-06 2001-12-31 Janssen Pharmaceutica Nv Farnesyl protein transferase inhibitors for treating arthropathies
US20040122011A1 (en) * 1998-12-23 2004-06-24 Pharmacia Corporation Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
US6713309B1 (en) 1999-07-30 2004-03-30 Large Scale Proteomics Corporation Microarrays and their manufacture
US7179638B2 (en) 1999-07-30 2007-02-20 Large Scale Biology Corporation Microarrays and their manufacture by slicing
US6806331B1 (en) * 2000-04-20 2004-10-19 Soken Chemical And Engineering Co., Ltd. Process for bulk polymerization using a catalyst
US7186693B2 (en) * 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
EP1545287B1 (de) * 2002-10-04 2012-12-05 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES Vasoregulierende verbindungen und anwendungsverfahren
JP5068428B2 (ja) * 2002-11-07 2012-11-07 アメリカ合衆国 血管新生および抗血管新生療法のための標的
US7189700B2 (en) * 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
ATE509956T1 (de) * 2006-06-08 2011-06-15 Helmholtz Zentrum Muenchen Spezifische proteaseinhibitoren und ihre verwendung in der krebstherapie
EP2280718B1 (de) * 2008-04-01 2016-07-27 Lucas Meyer Cosmetics Canada Inc. Extrakte von pflanzen des genus tsuga und ihre anwendung in der behandlung von entzündungen, reizungen und/oder infektionen
WO2017117130A1 (en) 2015-12-28 2017-07-06 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for inhibiting human immunodeficiency virus (hiv) release from infected cells
EP4067368A1 (de) 2016-06-01 2022-10-05 Athira Pharma, Inc. Verbindungen

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4091178A (en) * 1977-10-25 1980-04-24 Merck & Co Inc Substituted mercapto acid amides
US4235885A (en) * 1979-06-25 1980-11-25 E. R. Squibb & Sons, Inc. Inhibitors of mammalian collagenase
JPS5677296A (en) * 1979-11-29 1981-06-25 Ajinomoto Co Inc Tryptophane derivative and its preparation
US4327111A (en) * 1980-07-14 1982-04-27 E. R. Squibb & Sons, Inc. N-Substituted mercaptoacyl pripionamides
US4424354A (en) * 1981-06-12 1984-01-03 E. R. Squibb & Sons, Inc. Inhibitors of mammalian collagenase
US4371466A (en) * 1981-10-07 1983-02-01 American Home Products Corporation Mammalian collagenase inhibitors
GB8311286D0 (en) * 1983-04-26 1983-06-02 Searle & Co Carboxyalkyl peptide derivatives
US4568666A (en) * 1984-10-18 1986-02-04 G. D. Searle & Co. Carboxylalkyl peptide derivatives
US4826958A (en) * 1984-12-14 1989-05-02 Abbott Laboratories Renin inhibiting compounds
US4595700A (en) * 1984-12-21 1986-06-17 G. D. Searle & Co. Thiol based collagenase inhibitors
US4681966A (en) * 1985-02-21 1987-07-21 G. D. Searle & Co. Intermediate for thiol based collagenase inhibitors
US4826815A (en) * 1985-05-17 1989-05-02 Abbott Laboratories Renin inhibiting compounds
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4599361A (en) * 1985-09-10 1986-07-08 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4720486A (en) * 1985-10-18 1988-01-19 Monsanto Company Method of inhibiting vertebrate collagenase activity using peptide hydroxamic acid derivatives
JPS62114689A (ja) * 1985-11-12 1987-05-26 新日本製鐵株式会社 フルイ装置
US4857507A (en) * 1986-04-11 1989-08-15 Abbott Laboratories Angiotensinogen analogs
EP0258289A4 (en) * 1986-01-16 1991-01-02 Joseph Dellaria Peptide analogs
US4771038A (en) * 1986-01-21 1988-09-13 Ici Americas Inc. Hydroxamic acids
DK77487A (da) * 1986-03-11 1987-09-12 Hoffmann La Roche Hydroxylaminderivater
ZW23187A1 (en) * 1986-12-15 1988-06-29 Hoffmann La Roche Phosphinic acid derivatives
DK681287A (da) * 1986-12-24 1988-06-25 Beecham Group Plc Hidtil ukendte forbindelser
FR2609289B1 (fr) * 1987-01-06 1991-03-29 Bellon Labor Sa Roger Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes
BR8805647A (pt) * 1987-02-27 1989-10-31 Gist Brocades Nv Processo para clonagem molecular e expressao de genes que codificam para enzimas proteoliticas
ATE106087T1 (de) * 1987-03-17 1994-06-15 Res Corp Technologies Inc Synthetische inhibitoren von säugetier- collagenase.
US4891356A (en) * 1987-07-15 1990-01-02 Brigham & Women's Hospital Proteinase inhibitors for treatment of gastrointestinal ulcer disease
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds
JPH01146896A (ja) * 1987-12-04 1989-06-08 Fuji Yakuhin Kogyo Kk 新規なペプチジルヒドロキサム酸誘導体
JP2573006B2 (ja) * 1987-12-17 1997-01-16 富士薬品工業株式会社 新規なヒドロキサム酸誘導体
GB8729804D0 (en) * 1987-12-22 1988-02-03 Beecham Group Plc Novel compounds
EP0345104B1 (de) * 1988-06-02 1995-11-02 Merrell Dow Pharmaceuticals Inc. Alpha-glukosidase-Inhibitoren
GB8814813D0 (en) * 1988-06-22 1988-07-27 Beecham Group Plc Novel compounds
WO1990005141A1 (en) * 1988-11-10 1990-05-17 Australian Commercial Research & Development Limited Amino acid and peptide inhibitors of human leukocytic elastase and collagenase
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
GB8827308D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
EP0401963A1 (de) * 1989-04-13 1990-12-12 Beecham Group p.l.c. Phosphonopeptide mit kollagenase-inhibitierender Wirkung
JP2877509B2 (ja) * 1989-05-19 1999-03-31 アムジエン・インコーポレーテツド メタロプロテイナーゼ阻害剤
GB8919251D0 (en) * 1989-08-24 1989-10-04 British Bio Technology Compounds
GB8921326D0 (en) * 1989-09-21 1989-11-08 Beecham Group Plc Novel treatment
EP0517858A4 (en) * 1990-02-13 1993-07-28 Earl N. Doyle Process for producing n=c=o foams and the controlled pre- and post-expansion thereof
GB9008065D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
GB9008078D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
US5268384A (en) * 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
WO1992009565A1 (en) * 1990-12-03 1992-06-11 Celltech Limited Peptidyl derivatives
WO1992022523A2 (en) * 1991-06-14 1992-12-23 Research Corporation Technologies, Inc. Peptide derivatives of collagenase inhibitor
US5256657A (en) * 1991-08-19 1993-10-26 Sterling Winthrop, Inc. Succinamide derivative matrix-metalloprotease inhibitors
GB9122859D0 (en) * 1991-10-28 1991-12-11 Smithkline Beecham Plc Novel compounds
GB9200826D0 (en) * 1992-01-15 1992-03-11 Celltech Ltd Peptidyl derivatives
WO1993018173A2 (en) * 1992-03-11 1993-09-16 Xenova Limited Cd4 binding agents and inhibitors of collagenase and protein kinase c
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
WO1993021942A2 (en) * 1992-05-01 1993-11-11 British Biotech Pharmaceuticals Limited Use of mmp inhibitors
EP0642353A1 (de) * 1992-05-14 1995-03-15 Oncologix, Inc. Behandlung des vaskularen permeabilitätssyndroms und der kollagenase induzierten krankheit durch administrieren von inhibitoren der matrix-metalloproteinase(20.01.94)
GB9211706D0 (en) * 1992-06-03 1992-07-15 Celltech Ltd Peptidyl derivatives
GB9211707D0 (en) * 1992-06-03 1992-07-15 Celltech Ltd Peptidyl derivatives
AU666727B2 (en) * 1992-06-25 1996-02-22 F. Hoffmann-La Roche Ag Hydroxamic acid derivatives
AU5292193A (en) * 1992-10-02 1994-04-26 Merck & Co., Inc. N-(mercaptoacyl)peptidyl derivatives as antidegenerative agents
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
GB9318653D0 (en) * 1993-09-08 1993-10-27 Raychem Sa Nv Optical fibre organizer
UA48121C2 (uk) * 1993-11-04 2002-08-15 Сінтекс (С.Ш.А.) Інк. Інгібітори матричних металопротеаз і фармацетична композиція на їх основі
US5831004A (en) * 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5840698A (en) * 1994-10-27 1998-11-24 Affymax Technologies N.V. Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use

Also Published As

Publication number Publication date
US6307101B1 (en) 2001-10-23
DE69607615T2 (de) 2000-12-14
WO1996040738A1 (en) 1996-12-19
AU6269996A (en) 1996-12-30
AU700239B2 (en) 1998-12-24
CA2222923A1 (en) 1996-12-19
EP0832100A4 (de) 1998-09-02
EP0832100B1 (de) 2000-04-05
EP0832100A1 (de) 1998-04-01
US5831004A (en) 1998-11-03
DE69607615D1 (de) 2000-05-11
US5929278A (en) 1999-07-27

Similar Documents

Publication Publication Date Title
ATE191472T1 (de) Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen
GB8919251D0 (en) Compounds
ATE316786T1 (de) Behandlung von mukositis
DE69625691D1 (de) Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten
DE69627467D1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
DE60239343D1 (de) Mittel zur behandlung von erkrankungen, die mit knochenschwund einhergehen, mit ep4-agonist als wirkstoff
DE69929996D1 (de) Pharmazeutisches mittel zur behandlung von diabetes
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
ATE531688T1 (de) Verbindungen zur modulation des rage-rezeptors
DE60212613D1 (de) Doxycyclin zur behandlung von akne
DK1059934T3 (da) Matrixproteinpræparater til sårheling
DE69932939D1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
ATE162073T1 (de) Pharmazeutische zusammensetzung zur behandlung von osteoporose enthaltend xanthohumol
BR0114344A (pt) Retinóides para o tratamento de enfisema
BR0308957A (pt) Composto, composição farmacêutica, método para o tratamento de uma inflamação ou de uma desordem associada a uma inflamação em um paciente, uso dos compostos e processo para sua preparação
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
EP1488808A4 (de) Mittel zur behandlung von glomerulären erkrankungen
TR200200278T2 (tr) Kalsilitik bileşimler
DK0821969T3 (da) Medicinsk sammensætning omfattende TCF-II
DE50313329D1 (de) 1-phenyl-2-dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz
RU95110774A (ru) Олигонуклеотиды, терапевтические композиции, применение композиций
ID21369A (id) Komposisi farmasi untuk penyembuhan penyakit yang disebabkan oleh virus